世界中医药
文章摘要
引用本文:施敏,刘富林,夏旭婷,张婷,廖陈敏.龟甲胶治疗围绝经期失眠症的网络药理学研究[J].世界中医药,2022,(16):.  
龟甲胶治疗围绝经期失眠症的网络药理学研究
Testudinis Carapacis et Plastri Colla in the Treatment of Perimenopausal Insomnia Based on Network Pharmacology
投稿时间:2020-11-16  
DOI:10.3969/j.issn.1673-7202.2022.16.009
中文关键词:  龟甲胶  围绝经期  失眠  网络药理学  靶点  有效成分  通路  作用机制
English Keywords:Testudinis Carapacis et Plastri Colla  Perimenopausal period  Insomnia  Network pharmacology  Targets  Chemical components  Pathway  Mechanism
基金项目:国家自然科学青年基金项目(81603597);“东健”研究生创新项目(2020DJ04);湖南省教育厅优秀青年项目(19B424);湖南省中医药科研计划项目(201954)
作者单位
施敏,刘富林,夏旭婷,张婷,廖陈敏 湖南中医药大学长沙410208 
摘要点击次数: 573
全文下载次数: 0
中文摘要:
      目的:基于网络药理学方法分析龟甲胶治疗围绝经期失眠症的作用机制。方法:借助中药分子机制的生物信息学分析工具(BATMAN-TCM)检索龟甲胶所含中药的化学成分和作用靶基因,同时检索人类基因数据库(GeneCards)、人类孟德尔遗传综合数据库(OMIM)获得与围绝经期失眠症治疗相关的靶基因,借助Venny2.1平台对疾病靶基因与药物作用靶基因取交集,采用Cytoscape 3.7.2软件绘制疾病-靶基因-通路-中药成分网络图,利用String数据库构建靶基因蛋白质-蛋白质相互作用(PPI)网络图,采用R语言对靶基因进行GO功能、KEGG通路富集分析。结果:根据网络药理学相关数据库检索及分析得到龟甲胶所含中药的6个活性成分与围绝经期失眠症相关的ASPA、MPO、PPIG、EDN1、GLRA1等21个关键靶基因相互作用。GO功能富集分析得到相关条目共592个,其中生物过程514个,细胞组分49个,分子功能29个。主要涉及茶酚胺代谢、神经递质水平调节、突触传递,多巴胺能、氨基酸结合、神经递质受体活性等信号通路,KEGG通路富集分析筛选得到11条信号通路,主要涉及多巴胺能突触、苯丙胺成瘾、cAMP信号通路、TNF信号通路等。结论:龟甲胶可通过多靶点、多通路达到治疗围绝经期失眠症的效果,这为进一步深入探讨其作用机制提供了参考。
English Summary:
      To analyze the mechanism of Testudinis Carapacis et Plastri Colla(TCPC) in the treatment of perimenopausal insomnia based on network pharmacology.Methods:The chemical components and target genes of TCPC were retrieved from Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine(BATMAN-TCM),and target genes related to the treatment of perimenopausal insomnia were obtained from GeneCards and Online Mendelian Inheritance in Man(OMIM).The common target genes of the disease and the drug were obtained by virtue of Venny2.1.The disease-target gene-pathway-component network was plotted using Cytoscape 3.7.2.The protein-protein interaction(PPI) network of target genes was constructed using String,and the target genes underwent GO function and KEGG pathway enrichment analyses by R software.Results:According to the database retrieval and analysis of network pharmacology,six active components in TCPC interacted with 21 key target genes related to perimenopausal insomnia,including ASPA,MPO,PPIG,EDN1,and GLRA1.GO functional enrichment analysis yielded a total of 592 items,including 514 biological processes,49 cellular components,and 29 molecular functions,mainly involving catecholamine metabolism,neurotransmitter level regulation,synaptic transmission,dopamine,amino acid binding,and neurotransmitter receptor activity.KEGG pathway enrichment analysis screened out 11 signaling pathways,mainly including dopaminergic synapses,amphetamine addiction,cAMP signaling pathway,and TNF signaling pathway.Conclusion:TCPC can treat perimenopausal insomnia through multiple targets and multiple pathways,which provides a reference for further exploration of its mechanism of action.
查看全文  查看/发表评论  下载PDF阅读器